IMVARIA bags FDA authorisation for AI lung fibrosis diagnostic
Fibresolve is the first AI-powered diagnostic tool with billing codes recognised by the AMA, reported by the company.
17 January 2024
17 January 2024
Fibresolve is the first AI-powered diagnostic tool with billing codes recognised by the AMA, reported by the company.
Apple has sought to slow or even halt the ban on its watches containing pulse oximetry after it was found to have infringed two Masimo patents, but now is forced to remove the feature completely
Noctrix’s Nidra TOMAC therapy has been clinically validated to reduce RLS symptoms and improve sleep quality.
Rad AI will tap Google Cloud’s tools such as MedLM to advance its radiology workflow technology.
The study has been conducted at the University of Minnesota and gathered data for Sensydia's Cardiac Performance System.
The UNFO system offers a non-invasive alternative to traditional casting and surgical interventions.
Bloomlife MFM-Pro is a prescription-based wearable device designed to monitor maternal and fetal heart rates.
The trial comes off the back of a series of clinical trials dubbed the LIGHTSIDE studies that were able to show the therapy was well tolerated in dry age-related macular degeneration patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Cybersecurity is a growing market in the medical devices sector for several reasons. Medical devices often collect and contain vulnerable data, such as patient medical information. Legacy medical devices are a cause for concern because they likely were not designed with cyberattacks in mind. With the adoption of EHR systems, telemedicine measures, mobile health apps, and other connected devices, there is increased vulnerability to cyberattacks.
Give your business an edge with our leading industry insights.